November 8, 2016
The largest heart rhythm event in the UK – the Heart Rhythm Congress – took place at the International Convention Centre in Birmingham between 9–12th October 2016. This was a unique meeting showcasing the latest developments in arrhythmia care, together with arrhythmia patient day meetings, nurse education and specialist further accreditation for cardiac physiologists. Dr Rahul Mukherjee (Clinical Research Fellow in Cardiac Electrophysiology, Guys and St Thomas’ Hospital Biomedical Research Centre) reports on some of the highlights from this meeting.
October 19, 2016
We report the anticoagulation highlights from this key event in the cardiology calendar – the European Society of Cardiology (ESC) Congress – in this special edition of Arrhythmia Watch. Taking place in Rome, Italy, from 27th -31st August 2016, it attracted over 33,000 delegates from across the globe, including His Holiness Pope Francis. Studies selected for the much anticipated Hotline sessions included the ENSURE AF study looking at the use of edoxaban in cardioversion and the ANNEXA-4 study for reversal of acute bleeding.
January 14, 2016
Given the challenges of antithrombotic treatment in the elderly, the European Society of Cardiology (ESC) Working Group on Thrombosis task group has recently published an expert position paper on this important topic.1
November 24, 2015
Botox may prevent arrhythmias when injected into fat surrounding the heart after coronary artery bypass surgery (CABG), according to research published recently in Circulation: Arrhythmia and Electrophysiology.
October 30, 2015
Researchers have identified a gene which is linked to an increased risk of heart disease in women, according to a study published recently in Circulation: Cardiovascular Genetics.1
September 30, 2015
Many in the Department of Health, Public Health England and NHS England privately agree that the NHS Health Checks (NHSHC) programme is costly and ineffective, but are obliged in public to ‘toe the party line,’ according to a review published recently in the Journal of Public Health.1
July 30, 2015
There is huge variation across England in the use of non-vitamin K antagonist oral anticoagulants (NOACs) to reduce stroke risk in patients with atrial fibrillation (AF), according to a recent statement from the Atrial Fibrillation Association (AF Association) which condemns the new data as “completely unacceptable”.1
June 26, 2015
Uninterrupted anticoagulation with vitamin K antagonists during ablation and device implantation is recommended in a position paper from the European Heart Rhythm Association, published recently in EP Europace.1
May 28, 2015
Obesity is an important contributor to the atrial fibrillation (AF) epidemic, potentially explaining one-fifth of all cases, according to a study published recently in JACC: Clinical Electrophysiology.1
April 29, 2015
Hormone replacement therapy (HRT) does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke, according to a review of trials published recently in the Cochrane Library.1
Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.